Atlas Trials

The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma

Clinical trial NCT02116231 · UNKNOWN

Trial details

NCT number
NCT02116231
Sponsor
Cancer Hospital of Guangxi Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Effects of Chemotherapy
Start date
2014-04-01
Primary completion
2017-05-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.